Observational Study of Efficiency of Cytoflavin, in Patients With Ischemic Stroke Not Receiving Reperfusion Therapy

Stroke remains one of the main socially significant problems in the healthcare in the third millennium. The lethality in persons with history of stroke by the end of the 1st year of disease is high. A trend to increased frequency of stroke in the young age is observed during the last decade; third of patients is working-age individuals, out of whom only 15-20% returns to labor, and others remain disabled persons requiring constant medical and social support

NCT Number	NCT06514976
Lead Sponsor	POLYSAN Scientific & Technological Pharmaceutical Company
Conditions	Stroke, Acute, Stroke, Ischemic
Enrollment	562 participants
Start Date	2024-03-01
Primary Completion	2025-09-30 (estimated)
Study Completion	2025-11-01 (estimated)
Updated on ClinicalTrials.gov	2025-04-18